Literature DB >> 22504896

The effect of morphologic subtype on outcomes following the Sano-Norwood procedure.

Bari Murtuza1, Oliver Stumper, Douglas Wall, John Stickley, Timothy J Jones, David J Barron, William J Brawn.   

Abstract

OBJECTIVES: Controversy exists concerning outcomes of patients with different morphologic subtypes of hypoplastic left heart syndrome undergoing the Norwood procedure, in particular, aortic atresia-mitral stenosis (AA-MS) patients receiving a systemic-pulmonary modified Blalock-Taussig (mBT) shunt. We sought to determine the influence of known risk factors and morphology on early survival in our cohort of Sano-Norwood patients with right ventricle-pulmonary artery (RV-PA) conduits as the source of pulmonary blood flow.
METHODS: We studied early survival in patients with Sano-modified Norwood procedures from 2002 to 2010 and included both typical and atypical (including unbalanced atrioventricular canal defect) morphologic variants. We included a comparison group composed of classical Norwood patients with mBT shunts.
RESULTS: Of 264 Sano-Norwood patients, 49 had AA-MS and 30 had atypical morphologies. Weight ≤ 2.5 kg was associated with a poorer 1-year survival (P = 0.0007), though ascending aorta (AscAo) size <2.0 mm was not. We did not observe a difference in 30-day or 1-year Kaplan-Meier (K-M) survival across typical morphologic variants for either a Sano or mBTS group. Atypical variants exhibited a trend towards lower 30-day and 1-year survival in both Sano and mBTS groups though this was not significant. Direct comparison of 30-day K-M survival for Sano versus mBTS in AA-MS patients showed similar outcomes (P = NS).
CONCLUSIONS: Use of the RV-PA conduit results in good early survival, even in those with a small AscAo size. Atypical morphologic variants seem to do worse irrespective of the Sano or mBTS group. Further studies will be required to determine conclusively whether the RV-PA shunt confers protective effects in the AA-MS subgroup compared with the mBTS.

Entities:  

Mesh:

Year:  2012        PMID: 22504896     DOI: 10.1093/ejcts/ezs116

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  3 in total

1.  Negative Impact of the Left Ventricular Remnant Morphology on Systemic Right Ventricular Myocardial Deformation in Hypoplastic Left Heart Syndrome.

Authors:  Alan P Wang; Angela M Kelle; Meredith Hyun; Chelsea L Reece; Phillip M Young; Patrick W O'Leary; M Yasir Qureshi
Journal:  Pediatr Cardiol       Date:  2020-10-26       Impact factor: 1.655

2.  Impact of Left Ventricular Morphology on Adverse Outcomes Following Stage 1 Palliation for Hypoplastic Left Heart Syndrome: 20 Years of National Data From Sweden.

Authors:  Katrin Fricke; Mats Mellander; Katarina Hanséus; Phan-Kiet Tran; Mats Synnergren; Jens Johansson Ramgren; Annika Rydberg; Jan Sunnegårdh; Magnus Dalén; Gunnar Sjöberg; Constance G Weismann; Petru Liuba
Journal:  J Am Heart Assoc       Date:  2022-03-29       Impact factor: 6.106

3.  Early Outcomes of the Norwood Procedure in a Reference Center in Brazil.

Authors:  Rodrigo Freire Bezerra; Juliana Torres Pacheco; Sônia Meiken Franchi; Rosangela Belbuche Fittaroni; José Francisco Baumgratz; Rodrigo Moreira Castro; Luciana da Fonseca da Silva; José Pedro da Silva
Journal:  Arq Bras Cardiol       Date:  2022-08       Impact factor: 2.667

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.